Valuation: BioNTech SE

Market Cap 2.06TCr 2.35TCr 1.9TCr 1.75TCr 3.32TCr 2,24300Cr 3.38TCr 23TCr 8.9TCr 1,10500Cr 8.83TCr 8.64TCr 3,79800Cr P/E 2026 *
-18.5x
P/E 2027 * -18.2x
Enterprise Value 971.49Cr 1.11TCr 896.08Cr 827.62Cr 1.57TCr 1,05900Cr 1.6TCr 11TCr 4.2TCr 52TCr 4.17TCr 4.08TCr 1,79400Cr EV / Sales 2026 *
4.48x
EV / Sales 2027 * 5.06x
Free-Float
96.06%
Yield 2026 *
-
Yield 2027 * -
1 day-1.60%
1 week-2.60%
Current month-1.68%
1 month+6.20%
3 months-4.20%
6 months-10.46%
Current year-3.90%
1 week 91.02
Extreme 91.02
95.89
1 month 86.14
Extreme 86.14
98.81
Current year 79.52
Extreme 79.52
124
1 year 79.52
Extreme 79.52
124
3 years 76.53
Extreme 76.5301
131.49
5 years 76.53
Extreme 76.5301
464
10 years 12.52
Extreme 12.525
464
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 01/01/2018
Chief Executive Officer 60 02/06/2008
Director of Finance/CFO - 01/07/2025
Director TitleAgeSince
Chairman 55 02/06/2008
Director/Board Member 69 02/06/2008
Director/Board Member 65 01/01/2018
Date Insider Type Main position Quantity % Market Cap.
12/05Free

Chief Operating Officer

22,655 0.0094%
12/05Free

Chief Financial Officer

33,982 0.0141%
12/05Free

Head of Human Resources

18,879 0.0078%
Change 5-day change 1-year change 3-year change Capi.($)
-1.60%-2.60%-19.69%-14.84% 2.35TCr
-4.14%-7.44%+64.26%+119.36% 5.7TCr
+1.84%+1.65%+76.90%+95.68% 5.36TCr
-2.24%+3.65%+19.60%+466.72% 2.56TCr
+2.43%+5.86%+46.56%+0.42% 1.94TCr
-3.19%-0.29%+36.24%-27.32% 1.81TCr
-6.84%+2.18%+203.03%+348.11% 1.65TCr
+8.74%+10.46%+47.66% - 1.41TCr
-1.05%+1.75%+25.08%+196.28% 1.44TCr
-4.16%+1.36%+70.58%+143.85% 1.29TCr
Average -1.07%+1.65%+57.02%+147.58% 2.55TCr
Weighted average by Cap. -1.21%+0.58%+57.50%+138.84%

Financials

2026 *2027 *
Net sales 216.79Cr 247.85Cr 199.97Cr 184.69Cr 350.44Cr 24TCr 356.33Cr 2.39TCr 938.26Cr 12TCr 930.6Cr 910.35Cr 40TCr 223.07Cr 255.03Cr 205.76Cr 190.04Cr 360.59Cr 24TCr 366.66Cr 2.46TCr 965.44Cr 12TCr 957.56Cr 936.73Cr 41TCr
Net income -104.89Cr -119.91Cr -97Cr -89Cr -169.55Cr -11TCr -172.4Cr -1.16TCr -453.94Cr -5.63TCr -450.24Cr -440.44Cr -19TCr -116.46Cr -133.15Cr -107.42Cr -99Cr -188.26Cr -13TCr -191.43Cr -1.28TCr -504.05Cr -6.26TCr -499.93Cr -489.05Cr -22TCr
Net Debt -1.09TCr -1.24TCr -1TCr -924.69Cr -1.75TCr -1,18400Cr -1.78TCr -12TCr -4.7TCr -58TCr -4.66TCr -4.56TCr -2,00400Cr -928.56Cr -1.06TCr -856.48Cr -791.04Cr -1.5TCr -1,01200Cr -1.53TCr -10TCr -4.02TCr -50TCr -3.99TCr -3.9TCr -1,71500Cr
Logo BioNTech SE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Employees
7,807
Date Price Change Volume
11/26/11 $91.49 -1.60% 5,50,247
09/26/09 $92.98 -0.59% 8,16,162
08/26/08 $93.53 -0.81% 6,86,516
07/26/07 $94.29 +0.38% 8,96,013
06/26/06 $93.93 -3.71% 7,84,942
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
81.34EUR
Average target price
106.79EUR
Spread / Average Target
+31.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BNTX Stock